Preparing Synthetic Aβ in Different Aggregation States (original) (raw)

References

  1. Roychaudhuri R, Yang M, Hoshi MM, Teplow DB (2009) Amyloid beta-protein assembly and Alzheimer disease. The Journal of biological chemistry 284, 4749–53.
    Article PubMed CAS Google Scholar
  2. Rahimi, F., Shanmugam, A., and Bitan, G. (2008) Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer’s disease and related disorders. Curr Alzheimer Res 5, 319–41.
    Article PubMed CAS Google Scholar
  3. Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P., and Smith, S. O. (2006) High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 358, 106–19.
    Article PubMed CAS Google Scholar
  4. Huang, T. H., Yang, D. S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., and Chakrabartty, A. (2000) Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol 297, 73–87.
    Article PubMed CAS Google Scholar
  5. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. (1997) Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol 4, 119–25.
    Article PubMed CAS Google Scholar
  6. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer’s disease. Biochem 38, 8972–80.
    Article CAS Google Scholar
  7. Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S., and Emmerling, M. R. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease. J Biol Chem 271, 20631–35.
    Article PubMed CAS Google Scholar
  8. Legleiter, J., Czilli, D. L., Gitter, B., DeMattos, R. B., Holtzman, D. M., and Kowalewski, T. (2004) Effect of different anti-Abeta antibodies on Abeta fibrillogenesis as assessed by atomic force microscopy. J Mol Biol 335, 997–1006.
    Article PubMed CAS Google Scholar
  9. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277, 32046–53.
    Article PubMed CAS Google Scholar
  10. Stine, W. B., Jr., Dahlgren, K. N., Krafft, G. K., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278, 11612–22.
    Article PubMed CAS Google Scholar
  11. Manelli, A. M., Stine, W. B., Van Eldik, L. J., and LaDu, M. J. (2004) ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J Mol Neurosci 23, 235–46.
    Article PubMed CAS Google Scholar
  12. Manelli, A. M., Bulfinch, L. C., Sullivan, P. M., and LaDu, M. J. (2007) Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation. Neurobiol Aging 28, 1139–47.
    Article PubMed CAS Google Scholar
  13. White, J. A., Manelli, A. M., Holmberg, K. H., Van Eldik, L. J., and LaDu, M. J. (2005) Differential effects of oligomeric and fibrillar amyloid-beta1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18, 459–65.
    Article PubMed CAS Google Scholar
  14. Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Stine, W. B., Manelli, A., Sullivan, P., Pasternak, J. F., and LaDu, M. J. (2005) ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis 18, 75–82.
    Article PubMed CAS Google Scholar
  15. Bitan, G., Fradinger, E. A., Spring, S. M., and Teplow, D. B. (2005) Neurotoxic protein oligomers – what you see is not always what you get. Amyloid 12, 88–95.
    Article PubMed Google Scholar
  16. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P., and Landreth, G. E. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681–93.
    Article PubMed CAS Google Scholar
  17. Hickman, S. E., Allison, E. K., and El Khoury, J. (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J Neurosci 28, 8354–60.
    Article PubMed CAS Google Scholar
  18. El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., and Luster, A. D. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nature Med 13, 432–8.
    Article PubMed CAS Google Scholar
  19. Giunta, B., Zhou, Y., Hou, H., Rrapo, E., Fernandez, F., and Tan, J. (2008) HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide. Int J Clin Exp Pathol 1, 260–75.
    PubMed CAS Google Scholar
  20. Majumdar A, Chung H, Dolios G, Wang R, Asamoah N, Lobel P, Maxfield FR (2008) Degradation of fibrillar forms of Alzheimer’s amyloid beta-peptide by macrophages. Neurobiology of aging 29, 707–15.
    Article PubMed CAS Google Scholar
  21. Chung, H., Brazil, M. I., Soe, T. T., and Maxfield, F. R. (1999) Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer’s amyloid beta-peptide by microglial cells. J Biol Chem 274, 32301–8.
    Article PubMed CAS Google Scholar
  22. Brazil, M. I., Chung, H., and Maxfield, F. R. (2000) Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer’s disease amyloid fibrils by microglia. J Biol Chem 275, 16941–7.
    Article PubMed CAS Google Scholar
  23. Paresce, D. M., Ghosh, R. N., and Maxfield, F. R. (1996) Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553–65.
    Article PubMed CAS Google Scholar
  24. Parvathy S, Rajadas J, Ryan H, Vaziri S, Anderson L, Murphy GM, Jr. (2009) Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells. Neurobiology of aging 30, 1792–1804.
    Google Scholar
  25. Li, R., Shen, Y., Yang, L. B., Lue, L. F., Finch, C., and Rogers, J. (2000) Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J Neurochem 75, 1447–54.
    Article PubMed CAS Google Scholar
  26. Chafekar, S. M., Baas, F., and Scheper, W. (2008) Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. Biochim Biophys Acta 1782, 523–31.
    Article PubMed CAS Google Scholar
  27. Simakova, O., and Arispe, N. J. (2007) The cell-selective neurotoxicity of the Alzheimer’s Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity. J Neurosci 27, 13719–29.
    Article PubMed CAS Google Scholar
  28. Saavedra, L., Mohamed, A., Ma, V., Kar, S., and de Chaves, E. P. (2007) Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J Biol Chem 282, 35722–32.
    Article PubMed CAS Google Scholar
  29. Clifford, P. M., Zarrabi, S., Siu, G., Kinsler, K. J., Kosciuk, M. C., Venkataraman, V., D’Andrea, M. R., Dinsmore, S., and Nagele, R. G. (2007) Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res 1142, 223–36.
    Article PubMed CAS Google Scholar
  30. Smits, H. A., van Beelen, A. J., de Vos, N. M., Rijsmus, A., van der Bruggen, T., Verhoef, J., van Muiswinkel, F. L., and Nottet, H. S. (2001) Activation of human macrophages by amyloid-beta is attenuated by astrocytes. J Immunol 166, 6869–76.
    PubMed CAS Google Scholar
  31. Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., Cascorbi, I., Walker, L. C., Kroemer, H. K., Warzok, R. W., and Vogelgesang, S. (2007) MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s amyloid-beta peptides – implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol 17, 347–53.
    Google Scholar
  32. Liu, Y., and Schubert, D. (1997) Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium ­bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem 69, 2285–93.
    Article PubMed CAS Google Scholar

Download references